공간 오믹스 시장 규모, 점유율 및 성장 분석 : 기술별, 제품별, 워크플로우별, 샘플 유형별, 최종 용도별, 지역별 - 업계 예측(2026-2033년)

Global Spatial Omics Market size was valued at USD 402.96 Billion in 2024 and is poised to grow from USD 444.87 Billion in 2025 to USD 981.71 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).

The global spatial omics market is experiencing robust growth driven by advancements in sequencing technology, increased investment in innovative research, and the rising incidence of genetic disorders. The shift from decoding genes to analyzing cell types and biomarker interactions through spatial phenotyping is pivotal in this evolution. Key players in the market are providing diverse solutions that facilitate the quantification of around 1,800 RNA targets, effectively merging molecular analysis with spatial cellular context within tissues. This spatial genomic information is proving vital in diagnosing diseases, as it serves as a biomarker to identify medical conditions. Moreover, this technology is enhancing our understanding of critical biological processes, such as tissue organization and cellular regulation, thereby transforming approaches to disease treatment and management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segments Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The global demand for spatial omics tools has surged as individuals seek to understand and identify genetic disorders that are often passed down through generations. This drive is fueled by the desire to clarify uncertainties surrounding hereditary diseases and their underlying mechanisms. As more people become aware of the potential benefits of osmotic technology in diagnosing and researching these conditions, the interest in sophisticated spatial omics solutions continues to grow. Consequently, the market for spatial omics is expanding, reflecting an increasing appreciation for the role of advanced technological tools in enhancing our understanding of complex biological systems and disease management.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces several challenges that may inhibit its expansion. A key constraint is the limited availability of research expertise in this emerging field, which can stifle innovation and development. Additionally, the nascent nature of spatial omics research leads to a lack of widespread acceptance among researchers and practitioners, creating barriers to its integration into mainstream scientific studies. This scarcity of knowledge and familiarity can slow adoption rates and limit the overall growth potential of the market, as stakeholders may be hesitant to invest in a relatively uncharted area of study.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is witnessing significant growth, driven by the increasing demand for advanced diagnostic techniques that enhance the understanding of tumor microenvironments and cellular interactions. As researchers and healthcare providers recognize the importance of early malignancy detection, spatial omics is emerging as a pivotal tool for elucidating pathological mechanisms at the tumor boundary. The integration of high-throughput technologies and bioinformatics further accelerates the adoption of spatial omics, facilitating precise analysis of cellular landscapes. This trend is fostering collaborations between biotechnology firms and academic institutions, ultimately paving the way for innovative therapeutic strategies and improved patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
  • By Mode
  • Automated
  • Semi-automated
  • Manual
  • By Type
  • Sequencing Platforms
  • IHC
  • Microscopy
  • Flow Cytometry
  • Mass Spectrometry
  • Others
• Consumables
• Software
  • Bioinformatics Tools
  • Imaging Tools
  • Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Sample Preparation
• Instrumental Analysis
• Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• FFPE
• Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Academic & Translational Research Institutes
• Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2026-2033)

• North America (Technology, Product, Workflow, Sample Type, End-use)
  • US
  • Canada
• Europe (Technology, Product, Workflow, Sample Type, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product, Workflow, Sample Type, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• 10x Genomics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akoya Biosciences (formerly PerkinElmer) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• S2 Genomics, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RareCyte, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations